MANUEL ALBA - 20 Jun 2025 Form 4 Insider Report for Astera Labs, Inc. (ALAB)

Role
Director
Signature
/s/ Philip Mazzara, Attorney-in-Fact
Issuer symbol
ALAB
Transactions as of
20 Jun 2025
Net transactions value
-$2,031,853
Form type
4
Filing time
24 Jun 2025, 16:41:48 UTC
Previous filing
10 Jun 2025
Next filing
07 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ALBA MANUEL Director C/O ASTERA LABS, INC., 2345 NORTH FIRST STREET, SAN JOSE /s/ Philip Mazzara, Attorney-in-Fact 24 Jun 2025 0001134727

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALAB Common Stock Sale $248,247 -2,467 -0.57% $100.63 434,096 20 Jun 2025 By Casa Alameda 2007, LLC F1, F2, F3
transaction ALAB Common Stock Sale $125,755 -1,242 -0.29% $101.25 432,854 20 Jun 2025 By Casa Alameda 2007, LLC F1, F3, F4
transaction ALAB Common Stock Sale $1,100,257 -10,934 -0.55% $100.63 1,973,264 20 Jun 2025 By Alba Trust F1, F2, F5
transaction ALAB Common Stock Sale $557,595 -5,507 -0.28% $101.25 1,967,757 20 Jun 2025 By Alba Trust F1, F4, F5
holding ALAB Common Stock 5,000 20 Jun 2025 By spouse
holding ALAB Common Stock 2,351 20 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.0000 to $100.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.0000 to $101.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.